Bioptik Technology (4161)

Currency in TWD
26.85
0.00(0.00%)
Delayed Data·
4161 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
26.5528.00
52 wk Range
24.6035.70
Key Statistics
Bid/Ask
26.00 / 26.05
Prev. Close
34.1
Open
26.55
Day's Range
26.55-28
52 wk Range
24.6-35.7
Volume
-
Average Volume (3m)
123.37K
1-Year Change
-19.6108%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4161 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Healthcare Equipment & Supplies industry

Bioptik Tech Company Profile

Bioptik Technology Incorporation engages in the manufacturing, wholesale, and retail of biotechnology and medical equipment in Taiwan and internationally. It offers blood glucose, cholesterol, uric acid, hemoglobin and acid multi-function monitoring systems under the EasyMate, EasySure, and EasyTouch brand name, as well as PeTouch Glucose Monitoring System for Dogs and Cats. The company also provides dietary supplements, such as capsules, gel capsules, tablets, solutions, powder sachet, jelly, and gummy; cosmetic products, including sunscreen, cream/lotion, make-up removal, shampoo, time capsule, and toner/essence; and skin care products. It is involved in manufacturing of feed and food additive, aircraft and parts, and chemicals; wholesale and import and export trade of cosmetics raw materials, semi-finished products and finished products; cosmetics retail and wholesale; and special forestry management. Bioptik Technology Incorporation was founded in 1999 and is based in Zhunan, Taiwan.

Compare 4161 to Peers and Sector

Metrics to compare
4161
Peers
Sector
Relationship
P/E Ratio
21.5x23.6x−0.6x
PEG Ratio
−0.828.430.00
Price/Book
1.7x2.0x2.6x
Price / LTM Sales
1.9x2.8x3.3x
Upside (Analyst Target)
-43.4%44.5%
Fair Value Upside
Unlock20.4%5.0%Unlock
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.25%
Dividend Yield
1.12%
Industry Median 3.80%
Annualised payout
0.30
Paid unevenly
5-Years Growth
-12.08%
Growth Streak

Earnings

Latest Release
Nov 11, 2025
EPS / Forecast
0.45 / --
Revenue / Forecast
215.16M / --
EPS Revisions
Last 90 days

FAQ

What Is the Bioptik Tech (4161) Share Price Today?

The Bioptik Tech stock price today is 26.85 TWD.

What Stock Exchange Does Bioptik Tech (4161) Trade On?

Bioptik Tech is listed and trades on the Taipei Exchange.

What Is the Ticker (Stock Symbol) for Bioptik Tech?

The stock symbol (also called a 'ticker') for Bioptik Tech is "4161."

Does Bioptik Tech Pay Dividends? What’s The Current 4161 Dividend Yield?

Yes, 4161 Pays Dividends to its Shareholders. The current Bioptik Tech dividend yield is 1.12%.

What Is the Current Bioptik Tech Market Cap?

As of today, Bioptik Tech market cap is 1.61B TWD.

What Is Bioptik Tech's (4161) Earnings Per Share (TTM)?

The Bioptik Tech EPS is currently 1.25 (Trailing Twelve Months).

Is 4161 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Bioptik Tech moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bioptik Tech Stock Split?

Bioptik Tech has split 6 times. (See the 4161 stock split history page for full effective split date and price information.)

What is the current trading status of Bioptik Tech (4161)?

As of 26/02/2026, Bioptik Tech (4161) is trading at a price of 26.85 TWD, with a previous close of 34.10 TWD. The stock has fluctuated within a day range of 26.55 TWD to 28.00 TWD, while its 52-week range spans from 24.60 TWD to 35.70 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.